Overview
Basic Stats
The share price of Aperam S.A. - Depositary Receipt (Common Stock) as of June 3, 2024 is $29.07 / share.
The Factor Analysis chart (below right) shows a view of Aperam S.A. - Depositary Receipt (Common Stock) from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
Market Cap | |
EV | |
Shares Out. | 72.33 MM |
Earnings Date | |
EPS (TTM) | 2.65 |
Dividend Yield | |
Ex-Dividend Date | 2025-08-15 |
Borrow Rate | 15.85 |
Short Shares Avail. | 0.00 MM |
Short Interest | |
Short Float | |
Days to Cover | |
Risk Free Rate | 4.17 % |
Price Change (1 yr) | |
Volatility (1 yr) | |
Beta | |
Sharpe Ratio (1 yr) | |
Sortino Ratio (1 yr) |
PE Ratio | |
Price/Book | |
Price/TBV | |
Book/Market | |
EBIT/EV | |
EBIT(3yr avg)/EV | |
ROA | 0.04 |
ROE | 0.06 |
ROIC | 0.04 |
CROIC | -0.01 |
OCROIC | 0.06 |
Implied Volatility | |
Put/Call OI Ratio |
Price Target
The average one-year price target for Aperam S.A. - Depositary Receipt (Common Stock) is $35.73. The forecasts range from a low of $29.49 to a high of $45.37. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Aperam S.A. - Depositary Receipt (Common Stock). An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
Date | Analyst | Prior | Latest Recommendation |
Action |
---|---|---|---|---|
2023-11-27 | BNP PARIBAS EXANE | Neutral | Outperform | Upgrade |
2023-11-10 | DEGROOF PETERCAM | Hold | Hold | Maintains |
2023-10-27 | BNP PARIBAS EXANE | Neutral | Neutral | Maintains |
2023-09-26 | ING FM | Buy | Buy | Maintains |
2023-08-23 | BNP PARIBAS EXANE | Neutral | Neutral | Maintains |
2023-08-22 | BNP PARIBAS EXANE | Neutral | Neutral | Maintains |
2023-07-27 | DEGROOF PETERCAM | Hold | Hold | Maintains |
2023-07-26 | DEGROOF PETERCAM | Hold | Hold | Maintains |
2023-06-05 | BNP PARIBAS EXANE | Outperform | Neutral | Downgrade |
2023-06-04 | BNP PARIBAS EXANE | Outperform | Neutral | Downgrade |
2023-05-04 | ING FM | Buy | Buy | Maintains |
2023-05-03 | ING FM | Buy | Buy | Maintains |
2023-04-17 | BNP PARIBAS EXANE | Outperform | Neutral | Downgrade |
2022-09-27 | CREDIT SUISSE - EUROPE | Outperform | Neutral | Downgrade |
2022-09-26 | CREDIT SUISSE - EUROPE | Outperform | Neutral | Downgrade |
2022-07-29 | ODDO BHF | Buy | Buy | Maintains |
2022-07-28 | ODDO BHF | Buy | Buy | Maintains |
2022-06-01 | SOCIETE GENERALE | Hold | Buy | Upgrade |
2022-06-01 | SOCIETE GENERALE | Buy | Buy | Maintains |
2022-05-31 | SOCIETE GENERALE | Buy | Buy | Maintains |
2022-02-23 | BNP PARIBAS EXANE | Neutral | Outperform | Upgrade |
2022-02-22 | BNP PARIBAS EXANE | Neutral | Outperform | Upgrade |
2021-12-07 | CREDIT SUISSE - EUROPE | Neutral | Outperform | Upgrade |
2021-12-06 | CREDIT SUISSE - EUROPE | Neutral | Outperform | Upgrade |
2021-10-27 | ING FM | Hold | Buy | Upgrade |
2021-10-27 | ING FM | Buy | Buy | Maintains |
2021-10-26 | ING FM | Buy | Buy | Maintains |
2021-05-07 | CREDIT SUISSE - EUROPE | Neutral | Neutral | Maintains |
2021-05-06 | CREDIT SUISSE - EUROPE | Neutral | Neutral | Maintains |
2021-03-17 | BNP PARIBAS EXANE | Outperform | Neutral | Downgrade |
2021-03-17 | BNP PARIBAS EXANE | Neutral | Neutral | Maintains |
2021-03-16 | BNP PARIBAS EXANE | Neutral | Neutral | Maintains |
2020-11-17 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
2020-04-07 | ING FM | Hold | Hold | Maintains |
2019-02-06 | ABN AMRO BANK | Buy | Hold | Downgrade |
2018-08-01 | CREDIT SUISSE - EUROPE | Outperform | Neutral | Downgrade |
2018-05-09 | CREDIT SUISSE - EUROPE | Neutral | Outperform | Upgrade |
2017-10-12 | BNP PARIBAS EXANE | Neutral | Outperform | Upgrade |
2017-07-26 | BERENBERG | Buy | Buy | Maintains |
2017-05-12 | ING FM | Buy | Hold | Downgrade |
2017-02-09 | CREDIT SUISSE - EUROPE | Outperform | Neutral | Downgrade |
2016-11-10 | ABN AMRO BANK | Buy | Buy | Maintains |
2016-08-26 | ING FM | Hold | Buy | Upgrade |
2016-06-16 | RABOBANK EQUITY RESEARCH | Hold | Buy | Upgrade |
2016-05-05 | CREDIT SUISSE - EUROPE | Neutral | Outperform | Upgrade |
2015-12-04 | CAIXABANK BPI | Buy | Buy | Maintains |
2015-05-12 | SOCIETE GENERALE | Buy | Hold | Downgrade |
2015-03-09 | CAIXABANK BPI | Buy | Buy | Maintains |
2015-02-13 | SOCIETE GENERALE | Sell | Buy | Upgrade |
2014-12-24 | NOMURA | Buy | Buy | Maintains |
2014-12-09 | ING FM | Hold | Hold | Maintains |
2014-09-02 | BNP PARIBAS EXANE | Outperform | Neutral | Downgrade |
2014-05-02 | CREDIT SUISSE - EUROPE | Outperform | Neutral | Downgrade |
2014-04-15 | CAIXABANK BPI | Buy | Buy | Maintains |
2014-03-21 | NATIXIS | Buy | Buy | Maintains |
2014-03-13 | CREDIT SUISSE - EUROPE | Outperform | Outperform | Maintains |
2014-01-14 | RABOBANK EQUITY RESEARCH | Hold | Hold | Maintains |
2013-11-27 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
2013-09-13 | NATIXIS | Buy | Buy | Maintains |
2013-06-03 | DEGROOF PETERCAM | Buy | Buy | Maintains |
2012-12-11 | SOCIETE GENERALE | Sell | Sell | Maintains |
2024-08-08 | DEGROOF PETERCAM | Hold | Hold | Maintains |
2024-08-05 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
2024-05-28 | ING FM | Buy | Buy | Maintains |
2023-11-26 | BNP PARIBAS EXANE | Neutral | Outperform | Upgrade |
2023-11-09 | DEGROOF PETERCAM | Hold | Hold | Maintains |
2023-10-26 | BNP PARIBAS EXANE | Neutral | Neutral | Maintains |
2023-09-25 | ING FM | Buy | Buy | Maintains |
2025-04-03 | JEFFERIES | Buy | Buy | Maintains |
2025-04-02 | ODDO BHF | Buy | Buy | Maintains |
2025-02-25 | ING FM | Buy | Buy | Maintains |
2025-02-10 | DEGROOF PETERCAM | Hold | Hold | Maintains |
2025-01-05 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
2024-12-10 | ODDO BHF | Buy | Buy | Maintains |
2024-12-02 | DEGROOF PETERCAM | Hold | Hold | Maintains |
2024-11-26 | ING FM | Buy | Buy | Maintains |
2025-07-08 | DEGROOF PETERCAM | Hold | Hold | Maintains |
2025-07-02 | ODDO BHF | Buy | Buy | Maintains |
2025-05-27 | ING FM | Buy | Buy | Maintains |
2025-05-01 | JEFFERIES | Buy | Buy | Maintains |